ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 219 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,657,204 | -1.9% | 278,326 | -6.0% | 0.01% | 0.0% |
| Q2 2023 | $3,729,739 | -5.9% | 296,011 | -2.6% | 0.01% | -11.1% |
| Q1 2023 | $3,964,238 | -26.9% | 303,773 | -1.2% | 0.01% | -35.7% |
| Q4 2022 | $5,425,782 | -11.5% | 307,584 | -23.6% | 0.01% | -17.6% |
| Q3 2022 | $6,134,000 | +1.7% | 402,753 | -1.0% | 0.02% | +13.3% |
| Q2 2022 | $6,033,000 | -66.4% | 406,812 | -49.0% | 0.02% | -21.1% |
| Q1 2022 | $17,966,000 | +112.0% | 797,762 | +73.7% | 0.02% | +5.6% |
| Q4 2021 | $8,474,000 | -15.3% | 459,278 | -38.6% | 0.02% | -28.0% |
| Q3 2021 | $10,003,000 | -39.5% | 748,191 | -16.2% | 0.02% | -45.7% |
| Q2 2021 | $16,525,000 | +2.4% | 892,746 | -16.9% | 0.05% | -17.9% |
| Q1 2021 | $16,133,000 | +46.6% | 1,074,481 | +41.0% | 0.06% | +36.6% |
| Q4 2020 | $11,008,000 | +188.2% | 762,298 | +62.5% | 0.04% | +115.8% |
| Q3 2020 | $3,819,000 | – | 469,140 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 875,000 | $13,138,000 | 2.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 417,400 | $6,267,000 | 2.63% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 16,933,530 | $127,255,604,000 | 2.31% |
| Adirondack Research & Management Inc. | 123,148 | $1,849,000 | 2.19% |
| Smith, Graham & Co., Investment Advisors, LP | 966,216 | $14,508,000 | 1.18% |
| Lombard Odier Asset Management (Switzerland) SA | 839,521 | $12,605,000 | 0.84% |
| HENNESSY ADVISORS INC | 946,800 | $14,216,000 | 0.83% |
| Waterfront Wealth Inc. | 95,403 | $1,464,000 | 0.74% |
| Arjuna Capital | 84,697 | $1,272,000 | 0.62% |
| SummerHaven Investment Management, LLC | 62,844 | $944,000 | 0.58% |